Medicare Enrolled

Dr. Daniel Orlovich, M.D., PHARM. D.

Pharmacist · Van Nuys, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
6815 NOBLE AVE, Van Nuys, CA 91405
8189016600
In practice since 2011 (14 years)
NPI: 1891072070 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Orlovich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Orlovich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Orlovich

Dr. Daniel Orlovich is a pharmacist in Van Nuys, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Orlovich performed 2,492 Medicare services across 1,667 unique beneficiaries.

Between the years covered by Open Payments, Dr. Orlovich received a total of $9,200 from 14 pharmaceutical and/or device companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pharmacist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Orlovich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 10% volume in CA $9,200 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,492
Medicare services
Top 10% in CA for pharmacist
1,667
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~178 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,119 $106 $858
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
166 $71 $508
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
149 $133 $1,085
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
126 $106 $1,691
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
125 $102 $1,572
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
118 $57 $596
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
85 $45 $651
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
82 $189 $3,313
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
71 $57 $1,371
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
69 $83 $1,278
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
65 $76 $1,078
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
51 $116 $1,676
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
50 $84 $478
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
49 $64 $627
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
24 $90 $1,705
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
21 $193 $2,768
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint.
21 $66 $1,373
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
20 $58 $435
Nerve destruction for spine-pelvis joint pain
A procedure that destroys the nerves supplying the joint between the spine and pelvis to relieve pain. Imaging guidance is used to ensure accurate placement.
20 $173 $2,549
Knee nerve block injection with imaging guidance
An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement.
18 $67 $1,015
Injection of anesthetic agent and/or steroid into other nerve or branch 16 $26 $519
Destruction of nerve branches of knee using imaging guidance 14 $124 $2,038
X-ray of lower and sacral spine, minimum of 4 views
An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints.
13 $48 $328
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,200
Total received (2018-2024)
Avg $1,533/year across 6 years
Top 14% in CA for pharmacist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
14
Companies
116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,812 (63.2%)
Scientific / Research
Research funding and grants
$3,388 (36.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$562
2023
$1,079
2022
$2,335
2021
$1,075
2020
$4,010
2018
$139

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$201
Nevro Corp.
$183
Boston Scientific Corporation
$129
SPR Therapeutics, Inc
$48
Top 3 companies account for 91.4% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$3,388
Boston Scientific Corporation
$2,452
Nevro Corp.
$891
BOSTON SCIENTIFIC CORPORATION
$842
Abbott Laboratories
$467
SPR Therapeutics, Inc
$430
Relievant Medsystems, Inc.
$185
Medtronic, Inc.
$172
Mallinckrodt LLC
$124
PAINTEQ LLC
$105
MML US, Inc.
$61
Allergan, Inc.
$39
SI-BONE, Inc.
$28
Merck Sharp & Dohme Corporation
$14
Top 3 companies account for 73.2% of all-time payments
Associated products mentioned in payments ›
BOTOX · ETERNA · GENERAL PAIN MANAGEMENT · General - Pain Management · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · OCTRODE · OFIRMEV · Omnia · PAINTEQ · PROCLAIM · Proclaim IPG · ReActiv8 · SPECTRA WAVEWRITER · SPRINT PNS System · SUPERION · SYNCHROMED · Senza · Superion · Superion Indirect Decompression System · WaveWriter Alpha Prime 16
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pharmacist in Van Nuys?
Compare pharmacists in the Van Nuys area by procedure volume, costs, and industry payment transparency.
Browse pharmacists nearby

Geographic Context

Pharmacists within 10 mi
5,361
Per 100K population
54.4
County median income
$87,760
Nearest hospital
VALLEY PRESBYTERIAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Orlovich is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 14% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Orlovich experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Orlovich performed 1,119 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Orlovich receive payments from pharmaceutical companies?
Yes. Dr. Orlovich received a total of $9,200 from 14 companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Orlovich's costs compare to other pharmacists in Van Nuys?
Dr. Orlovich's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Orlovich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →